Trial Profile
Immunotherapy With the Highly Activated NK Cells for AIDS Patients of Good Viral Suppression But Poor Immune Rebuilding
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Natural killer cell therapy Shenzhen Hank Bioengineering Institute (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 16 Nov 2017 New trial record